|
|
Post by mnholdem on May 11, 2018 10:27:59 GMT -5
White House Prepares to Roll Out Drug Pricing Reform Proposal Package Today Published: May 11, 2018 By Alex Keown
Excerpt:
Trump’s proposals, which can largely be done through executive orders, according to reports, will seek to “increase competition and improve the negotiation of drug prices, as well as reduce consumers' out-of-pocket spending on medicines and create incentives to lower list prices,” CNN reported.
---
Politico noted in its report that some generic prescription drugs could become free to seniors on Medicare under the planned proposal.
---
Drug pricing rebates will likely be addressed by the administration. The government will be taking a closer look at the relationship between insurers and Prescription Benefits Managers. Pharmacy benefits managers play an increasingly important role in the price consumers pay for drugs. In an analysis of the role PBMs play in the pricing of medications, the Los Angeles Times said that although drug companies set the list price, “virtually no PBM pays that price for brand-name drugs.”
Full details of the plan will be revealed Friday afternoon at 2 p.m. EDT.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 11, 2018 12:34:46 GMT -5
President Trump is set to announce his plan to corral drug prices in a speech set to begin at 2:00 pm ET today. According to administration officials the plan will not include a call to Congress to allow Medicare to negotiate drug prices, a move currently prohibited under federal law. seekingalpha.com/news/3355875-trump-plan-drug-prices-announced-afternoon------------------------------ More gimmicks. |
|
|
|
Post by peppy on May 11, 2018 13:04:33 GMT -5
let's hear it. volume came into MNKD on a Friday afternoon.
|
|
|
|
Post by peppy on May 11, 2018 13:12:28 GMT -5
"we are eliminating the middle man"
FDA released generics
There it is.
weeeeeeeeee
|
|
|
|
Post by peppy on May 11, 2018 13:13:26 GMT -5
we get afrezza generic, people can decide. it is a pennies business and pennies add up
ditto india, we want generic.
the SPX 15 min head and shoulders is going to take out yesterday.
"fda will speed up the process for over the counter."
|
|
|
|
Post by peppy on May 11, 2018 13:20:44 GMT -5
President Trump is set to announce his plan to corral drug prices in a speech set to begin at 2:00 pm ET today. According to administration officials the plan will not include a call to Congress to allow Medicare to negotiate drug prices, a move currently prohibited under federal law. seekingalpha.com/news/3355875-trump-plan-drug-prices-announced-afternoon------------------------------ More gimmicks. Quote: " a move currently prohibited under federal law." tRump :"we are going to see those prices go down" "it will happen and it will happen quickly" reply: There is going to be a "bill" Government programs and Medicare. |
|
|
|
Post by peppy on May 11, 2018 13:24:22 GMT -5
the middle man = Pharmacy Business Managers.
"eliminate the middle man"
|
|
|
|
Post by mnkdfann on May 11, 2018 14:03:45 GMT -5
we get afrezza generic, people can decide. it is a pennies business and pennies add up What are you saying? Force Mannkind to teach generic drug manufacturers how to produce generic Afrezza? Good for diabetics, not good for Mannkind's business model. |
|
|
|
Post by peppy on May 11, 2018 14:06:06 GMT -5
we get afrezza generic, people can decide. it is a pennies business and pennies add up What are you saying? Force Mannkind to teach generic drug manufacturers how to produce generic Afrezza? Good for diabetics, not good for Mannkind's business model. no, I am saying, as you know Afrezza is made with NPH, generic insulin, I would love for Afrezza to be over the counter, here and in India. That is what I am saying. What do you think? |
|
|
|
Post by peppy on May 11, 2018 14:42:24 GMT -5
The theme of the president’s initiative is “American patients first,” and his plan takes aim at what the White House calls “foreign freeloading.” The administration will, as expected, put pressure on foreign countries to relax drug price controls, in the belief that pharmaceutical companies can then lower prices in the United States.
“Other countries use socialized health care to command unfairly low prices from U.S. drugmakers,” said a summary provided by the White House on Thursday. “This places the burden of financing drug development largely on American patients and taxpayers, subsidizes foreign consumers, and reduces innovation and the development of new treatments.”
The United States spends well over $300 billion a year on prescription drugs sold at pharmacies and other retail outlets, and Medicare and Medicaid account for nearly 40 percent of that spending, according to the Department of Health and Human Services.
Mr. Trump plans to criticize brand-name drug manufacturers for setting high list prices and for trying to stifle competition by delaying the marketing of lower-cost generic drugs. He is also expected to criticize pharmacy benefit managers, saying they profit from rebates paid by drug companies but do not pass on much of the savings to patients.
Mr. Trump has repeatedly said that drug companies are “getting away with murder.”
In his State of the Union address in January, he said that “fixing the injustice of high drug prices” was one of his top priorities for 2018. “And prices will come down substantially,” he said. “Watch.”
|
|
|
|
Post by lennymnkd on May 11, 2018 14:57:09 GMT -5
Or put generics on the platform Any advantage to us ?
|
|
|
|
Post by dreamboatcruise on May 11, 2018 16:50:01 GMT -5
What are you saying? Force Mannkind to teach generic drug manufacturers how to produce generic Afrezza? Good for diabetics, not good for Mannkind's business model. no, I am saying, as you know Afrezza is made with NPH, generic insulin, I would love for Afrezza to be over the counter, here and in India. That is what I am saying. What do you think? I'm sure just a typo... NPH is altered for longer effect. Afrezza is made from Regular Insulin. Unless Mannkind radically lowered the price (and thus market cap potential for us investors) few could afford it OTC. I seriously doubt FDA would approve as OTC until long term safety trials are complete. |
|
|
|
Post by peppy on May 11, 2018 17:18:14 GMT -5
The Over the counter potential for afrezza has been discussed before. It is spirometry that would stop it, and in this country afrezza requires spirometry.
sorry, Afrezza = regular insulin.
|
|
|
|
Post by dreamboatcruise on May 11, 2018 17:31:38 GMT -5
The Over the counter potential for afrezza has been discussed before. It is spirometry that would stop it, and in this country afrezza requires spirometry. You could be right that the only barrier would be spirometry, but I doubt it. I think you assume that Afrezza would somehow fall within the regulatory precedence of older insulins, but I think that is a mistake... it being a drug/device combo and a different delivery route. The insulins that are available over the counter existed before there was an FDA and thus have a unique status. If they were to just now be coming into the market there is certainly no guarantee the FDA wouldn't make them prescription only. Since Afrezza is drug + medical device that likely means the FDA would need to actively decide to make it OTC... and as stated, they might not even approve the older insulins as OTC if they were making that decision now. Just my take. Predicting what the FDA will do is certainly not something I've had a great deal of success with... such as losing lots of money on MNKD call options when CRLs were issued rather than approval. |
|
|
|
Post by mnkdfann on May 11, 2018 18:55:03 GMT -5
The Over the counter potential for afrezza has been discussed before. It is spirometry that would stop it, and in this country afrezza requires spirometry. sorry, Afrezza = regular insulin. Perhaps I misunderstand what you are saying, but you seem to be equating OTC insulin with generic insulin and prescription insulin with a non-generic product. I've no experience with how your pharmacies work, but that model does not sound like what we have here (in Canada). That is, generic drugs here may be prescription or be OTC. Earlier, you asked whether I think OTC insulin is a good idea. I am not a medical doctor, but I think it is complicated. I think it would be good for people who have the know how to deal with it, but I suspect a lot of people might misuse an OTC insulin and / or take it to address a problem they do not have. |
|
